Quantification of in-vivo P-glycoprotein transport and modulation in the blood-brain barrier with PET.

被引：0
|
作者：
Hendrikse, NH [1 ]
Eriks-Fluks, E [1 ]
Vaalburg, W [1 ]
Willemsen, AT [1 ]
机构：
[1] Univ Groningen Hosp, Groningen, Netherlands
来源：
JOURNAL OF NUCLEAR MEDICINE | 2000年 / 41卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1153
引用
收藏
页码：262P / 262P
页数：1
相关论文
共 50 条
  • [41] Inhibition of P-Glycoprotein Function by Procyanidine on Blood-Brain Barrier
    He, Ling
    Zhao, Chuan
    Yan, Ming
    Zhang, Lu-Yong
    Xia, Yuan-Zheng
    PHYTOTHERAPY RESEARCH, 2009, 23 (07) : 933 - 937
  • [42] P-glycoprotein activity in an in vitro blood-brain barrier model
    Joly, B
    Fardel, O
    Lecureur, V
    Chesne, C
    Puozzo, C
    Guillouzo, A
    BIOLOGY AND PHYSIOLOGY OF THE BLOOD-BRAIN BARRIER: TRANSPORT, CELLULAR INTERACTIONS, AND BRAIN PATHOLOGIES, 1996, 46 : 191 - 196
  • [43] Imaging P-glycoprotein at the human blood-brain barrier - Reply
    Unadkat, Jashvant D.
    Link, Jeanne M.
    Mankoff, David A.
    Muzi, Mark
    Collier, Ann C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 80 (03) : 303 - 304
  • [44] Can P-glycoprotein at the human blood-brain barrier be induced by rifampin? A PET imaging study
    Liu, Li
    Collier, Ann C.
    Link, Jeanne M.
    Domino, Karen B.
    Eary, Janet F.
    Mankoff, David A.
    Hsiao, Peng
    Deo, Anand K.
    Unadkat, Jashvant D.
    DRUG METABOLISM REVIEWS, 2011, 43 : 30 - 31
  • [45] ON THE ROLE OF P-GLYCOPROTEIN FUNCTION IN THE BLOOD-BRAIN BARRIER IN PHARMACORESISTANCE: A PET STUDY IN EPILEPTIC RATS
    Voskuyl, R. A.
    Syvanen, S.
    Luurtsema, G.
    Molthoff, C. F.
    Windhorst, A. D.
    Huisman, M. C.
    Lammertsma, A. A.
    de Lange, E. C.
    EPILEPSIA, 2009, 50 : 337 - 337
  • [46] In Vivo Saturation of the Transport of Vinblastine and Colchicine by P-Glycoprotein at the Rat Blood–Brain Barrier
    Salvatore Cisternino
    Christophe Rousselle
    Marcel Debray
    Jean-Michel Scherrmann
    Pharmaceutical Research, 2003, 20 : 1607 - 1611
  • [47] Modulation of P-glycoprotein at the blood-brain barrier: Opportunities to improve central nervous system pharmacotherapy
    Miller, David S.
    Bauer, Bjoern
    Hartz, Anika M. S.
    PHARMACOLOGICAL REVIEWS, 2008, 60 (02) : 196 - 209
  • [48] Quantification of P-glycoprotein function at the human blood-brain barrier using [18F]MC225 and PET
    Mossel, P.
    Willemsen, A. T.
    Varela, L. Garcia
    Arif, W.
    Boellaard, R.
    Elsinga, P. H.
    de Deyn, P.
    Dierckx, R. A.
    Lammertsma, A. A.
    Bartels, A. L.
    Luurtsema, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S295 - S296
  • [49] Quantification of P-glycoprotein function at the human blood-brain barrier using [18F]MC225 and PET
    Pascalle Mossel
    Wejdan M. Arif
    Giordana Salvi De Souza
    Lara Garcia Varela
    Chris W. J. van der Weijden
    Hendrikus H. Boersma
    Antoon T. M. Willemsen
    Ronald Boellaard
    Philip H. Elsinga
    Ronald J. H. Borra
    Rudi A. J. O. Dierckx
    Adriaan A. Lammertsma
    Anna L. Bartels
    Gert Luurtsema
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 3917 - 3927
  • [50] Inhibition of P-glycoprotein:: Rapid assessment of its implication in blood-brain barrier integrity and drug transport to the brain by an in vitro model of the blood-brain barrier
    Fenart, L
    Buée-Scherrer, V
    Descamps, L
    Duhem, C
    Poullain, MG
    Cecchelli, R
    Dehouck, MP
    PHARMACEUTICAL RESEARCH, 1998, 15 (07) : 993 - 1000
12345